Stock BIOBLAST PHARMA LTD
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Calendar Bioblast Pharma Ltd Nasdaq

Equities

IL0011319527

Chart calendar Bioblast Pharma Ltd

9b8fb262e.KF3kU2ff7l45bFjnCkFR1jvd5EOcZ1aWAtGs21i2MZU.UhirZQmn2jt_GRWxRylk5wmkiSnlDzPaYI7gmC78WvkYGKlqDuiiC18-YA~9bdd365b0e4b36d8fb02d1436bfd4b2f

Upcoming events on Bioblast Pharma Ltd

2024-05-23 Q1 2024 Earnings Release (Projected)
2025-05-22 Q1 2025 Earnings Release (Projected)

Past events on Bioblast Pharma Ltd

2024-04-12 08:30 am Allocetra Phase II Trial Results Call
2024-03-20 RedChip Investor Group Call
2023-09-12 05:00 pm H.C. Wainwright Global Investment Conference
2023-06-26 08:00 am Q1 2023 Earnings Release
2023-06-09 11:30 am Jefferies Global Healthcare Conference
2023-06-01 12:00 pm International Society for Cell & Gene Therapy Meeting - Poster No:1057
2023-06-01 12:00 pm International Society for Cell & Gene Therapy Meeting - Poster No:1003
2023-05-31 01:00 pm International Society for Cell & Gene Therapy Meeting - Poster No:805
2022-12-05 08:00 am Q3 2022 Earnings Release
2022-11-09 Society for Immunotherapy of Cancer Meeting
2022-10-06 02:30 pm Macrophage directed Therapies Summit
2022-09-15 09:20 am Cantor Cell and Genetic Medicines Conference - Panel
2022-09-14 03:10 pm Baird Global Healthcare Conference
2022-09-13 11:00 am H.C. Wainwright Global Investment Conference
2022-09-11 European Society for Medical Oncology
2022-08-22 08:00 am Interim 2022 Earnings Release
2022-06-09 01:00 pm Jefferies Healthcare Conference
2022-06-05 09:00 am American Society of Clinical Oncology Meeting
2022-05-22 H.C. Wainwright Global Investment Conference - Pre-Recorded
2022-04-29 08:41 am FY 2021 Earnings Release

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00

EBITDA
Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00

EBIT
Million USD		Released
Forecast
Spread 		-8,62
-8,08
-6.67%		-9,79
-8,79
-11.35%		-19,3
-17,0
-13.73%		-25,8
-24,0
-7.7%		-29,4
-23,8
-23.72%
-16,3

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		-14,5
-15,6
7.04%		-31,1
-30,9
-0.61%		-29,1
-25,2
-15.47%
-16,3

Net income
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		-14,5
-15,6
7.04%		-31,1
-30,9
-0.61%		-29,1
-25,2
-15.47%
-16,3

EPS
USD		Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		-0,81
-0,86
5.81%		-1,69
-1,68
-0.6%		-1,56
-1,36
-14.71%
-0,86

Announcement Date30/04/2030/04/2129/04/2231/03/2329/03/24-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00


0,00


0,00


0,00




EBIT
Million USD		Released
Forecast
Spread 		-7,81
-4,85
-61.11%		-6,40
-8,10
20.94%		-5,87
-7,70
23.75%		-5,68
-5,30
-7.11%		-7,85
-6,00
-30.75%		-6,78
-7,30
7.08%		-6,65
-7,00
5.01%		-5,63
-6,00
6.2%		-10,3
-4,70
-119.89%
-4,60


-4,40


-3,80


-3,50




Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-4,74
-5,31
10.81%		-8,23
-7,59
-8.44%		-9,91
-8,20
-20.89%		-5,73
-5,31
-8.05%		-7,19
-7,00
-2.7%		-7,22
-7,31
1.19%		-6,79
-8,00
15.1%		-5,96
-6,01
0.72%		-9,10
-5,20
-74.9%
-4,60


-4,40


-3,80


-3,50




Net income
Million USD		Released
Forecast
Spread 		-4,74
-5,31
10.81%		-8,23
-7,59
-8.44%		-9,91
-8,20
-20.89%		-5,73
-5,31
-8.05%		-7,19
-7,00
-2.7%		-7,22
-7,31
1.19%		-6,79
-8,00
15.1%		-5,96
-6,01
0.72%		-9,10
-5,20
-74.9%
-4,60


-4,40


-3,80


-3,50




EPS
USD		Released
Forecast
Spread 		-0,26
-0,28
7.14%		-0,45
-0,41
-9.76%		-0,54
-0,45
-20%		-0,31
-0,29
-6.9%		-0,39
-0,38
-2.63%		-0,39
-0,40
2.5%		-0,37
-0,43
13.95%		-0,32
-0,32
0%		-0,48
-0,28
-71.43%
-0,25


-0,24


-0,20


-0,17


-0,14

Announcement Date29/04/2227/05/2222/08/2202/12/2231/03/2316/06/2301/09/2309/11/2329/03/24-----

Upcoming sector events for Bioblast Pharma Ltd

2024-07-23 VIKING THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected)
2024-07-24 BIOCON LIMITED: Q1 2025 Earnings Release (Projected)
2024-07-25 01:00 am ARGENX SE: Q2 2024 Earnings Release
2024-07-29 RHYTHM PHARMACEUTICALS, INC.: Q2 2024 Earnings Release (Projected)
2024-07-29 NEUROCRINE BIOSCIENCES, INC.: Q2 2024 Earnings Release (Projected)
2024-07-29 CEREVEL THERAPEUTICS HOLDINGS, INC.: Q2 2024 Earnings Release (Projected)
2024-07-30 CASSAVA SCIENCES, INC.: Q2 2024 Earnings Release (Projected)
2024-07-30 SPRINGWORKS THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected)
2024-07-30 XENCOR, INC.: Q2 2024 Earnings Release (Projected)
2024-07-30 SAREPTA THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected)
More events

Past sector events for Bioblast Pharma Ltd

2024-05-17 07:00 am AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release
2024-05-16 07:46 am BIOCON LIMITED: Q4 2024 Earnings Release
2024-05-16 01:00 am ZEALAND PHARMA A/S: Q1 2024 Earnings Release
2024-05-15 08:05 am THIRD HARMONIC BIO, INC.: Q1 2024 Earnings Release
2024-05-15 07:00 am CABALETTA BIO, INC.: Q1 2024 Earnings Release
2024-05-14 TAIMED BIOLOGICS INC.: Q1 2024 Earnings Release
2024-05-15 04:01 pm CELCUITY INC.: Q1 2024 Earnings Release
2024-05-14 04:05 pm ENLIVEN THERAPEUTICS, INC.: Q1 2024 Earnings Release
2024-05-14 04:00 pm ARCUTIS BIOTHERAPEUTICS, INC.: Q1 2024 Earnings Release
2024-05-14 08:00 am IMMUNOME, INC.: Q1 2024 Earnings Release
  1. Stock Market
  2. Equities
  3. ENLV Stock
  4. Stock
  5. Calendar Bioblast Pharma Ltd
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW